Not applicableUnknownNCT04116086What this trial is testingUsing PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early StageWho this might be right forProstate Cancer Sheba Medical Center 50
Early research (Phase 1)Ended earlyNCT03619655What this trial is testingAssessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to TherapyWho this might be right forProstate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Not applicableStudy completedNCT05022576What this trial is testingRobotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate BiopsyWho this might be right forProstate Cancer Post Graduate Institute of Medical Education and Research, Chandigarh 78
Not applicableLooking for participantsNCT06859203What this trial is testingA Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PETWho this might be right forBiochemical Recurrence of Malignant Neoplasm of Prostate Technical University of Munich 94
Testing effectiveness (Phase 2)Study completedNCT02488070What this trial is testing68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate CancerWho this might be right forRecurrent Prostate Carcinoma Stanford University 10
Not applicableLooking for participantsNCT06209853What this trial is testingCorrelation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer PatientWho this might be right forProstatic Neoplasms Assiut University 59
Not applicableUnknownNCT03507595What this trial is testingEvaluation of the Metastasis and Recurrence of Prostate CancerWho this might be right forProstate Cancer (Diagnosis)Prostate Cancer MetastaticProstate Cancer Recurrent+1 more Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 400
Not applicableStudy completedNCT07485257What this trial is testingMolecular Profiling of MRI-PSMA PET Discordance in Prostate CancerWho this might be right forProstate CancerMolecular ImagingTranscriptomics+2 more IRCCS San Raffaele 30
Testing effectiveness (Phase 2)Ended earlyNCT03841760What this trial is testingSUV on PSMA PET/CT in Non-Prostate TumorsWho this might be right forCancer Sir Mortimer B. Davis - Jewish General Hospital 3
Not applicableLooking for participantsNCT07531329What this trial is testingDelayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate CancerWho this might be right forTreatment-naive Prostate CancerSuspected Prostate CancerMolecular Imaging Xijing Hospital 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06059469What this trial is testingPSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.Who this might be right forTNBC - Triple-Negative Breast Cancer Jules Bordet Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT07025369What this trial is testingAndrogen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA TrialWho this might be right forProstate AdenocarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+1 more Mayo Clinic 30
Early research (Phase 1)Ended earlyNCT04279561What this trial is testingEffect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate CancerWho this might be right forCastration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8+2 more Jonsson Comprehensive Cancer Center 9
Very early researchUnknownNCT02691169What this trial is testingIntegrated 18F-labelled PSMA ProjectWho this might be right forProstate Cancer St. Joseph's Healthcare Hamilton 10
Not applicableLooking for participantsNCT06320223What this trial is testingPROMISE PET Registry on PSMA-PET and Outcome in Prostate CancerWho this might be right forProstate CancerPET/CTSurvivorship+1 more University Hospital, Essen 10,000
Not applicableStudy completedNCT06460454What this trial is testingPROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) ProgressingWho this might be right forProstate Cancer Central Hospital, Nancy, France 100
Not applicableStudy completedNCT05522257What this trial is testingPSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell CarcinomasWho this might be right forSarcoma,Soft TissueUrothelial Carcinoma Leiden University Medical Center 25
Not applicableStudy completedNCT05079828What this trial is testingHead-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007Who this might be right forProstate Cancer Insel Gruppe AG, University Hospital Bern 100
Not applicableNot Yet RecruitingNCT07639801What this trial is testing68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid TumorsWho this might be right forProstate CancerHepatocellular CarcinomaOvarian Cancer+4 more Peking University Cancer Hospital & Institute 20
Not applicableNot Yet RecruitingNCT06901492What this trial is testingThe Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate PunctureWho this might be right forPSMA PET/CTProstate CancerMpMRI Nanjing First Hospital, Nanjing Medical University 120